Quinolines derivatives as novel anticancer agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10179770
APP PUB NO 20160280653A1
SERIAL NO

14777917

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENOSCIENCE PHARMA13006 MARSEILLE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bassissi, Firas Marseilles, FR 6 1
Beret, Antoine Marseilles, FR 4 1
Brun, Sonia Aix en Provence, FR 4 0
Camus, Claire Marseilles, FR 1 0
Courcambeck, Jerome Marseilles, FR 3 23
Halfon, Philippe Marseilles, FR 12 29
Nallet, Jean Pierre Montanay, FR 1 0
Nicolas, Gregory Marseilles, FR 2 0
Petit, Serge Cusy, FR 17 52

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 15, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 15, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00